Sustained gallbladder stasis promotes cholesterol gallstone formation in the ground squirrel

Hepatology

Volumn 26, Issue 4, 1997, Pages 831-836

  Xu, Qi Wei ^a   Mantle, Michèle ^a   Pauletzki, Jürgen G ^a   Shaffer, Eldon A ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DEVAZEPIDE; MUCIN;

ANIMAL MODEL; ARTICLE; BILE; CHOLESTEROL STONE; CONTROLLED STUDY; GALLBLADDER; GALLBLADDER CONTRACTION; GALLSTONE FORMATION; MALE; NONHUMAN; PRIORITY JOURNAL; SQUIRREL;

EID: 0030767542     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260404     Document Type: Article

References (41)

1. Shaffer EA. Abnormalities in gallbladder function in cholesterol gallstone disease: bile and blood, mucosa and muscle - the list lengthens. Gastroenterology 1992;102:1808-1812.
2. Pomeranz IS, Shaffer EA. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology 1985;88:787-791.
3. Behar J, Lee KY, Thompson WR, Biancani P. Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology 1989; 97:1479-1484.
4. LaMont JT, Afdhal NH. Biliary tract. Curr Opin Gastroenterol 1993;9: 787-790.
5. LaMorte WW. Biliary motility and abnormalities associated with cholesterol cholelithiasis. Curr Opin Gastroenterol 1993;9:810-816.
6. Brugge WR, Brand DL, Arkins H, Lane B, Abel WG. Gallbladder dyskinesia in chronic acalculous cholecystitis. Dig Dis Sci 1986;31:461-467.
7. Spengler U, Sackmann M, Sauerbruch T, Holl J, Paumgartner G. Gallbladder motility before and after extracorporeal shock-wave lithotripsy. Gastroenterology 1989;96:860-863.
8. Kaminski DL. Arachidonic acid metabolites in hepatobiliary physiology and disease. Gastroenterology 1989;97:781-792.
9. Fridhandler TM, Davison JS, Shaffer EA. Defective gallbladder contractility in the ground squirrel and prairie dog during the early stages of cholesterol gallstone formation. Gastroenterology 1983;85:830-836.
10. MacPherson BR, Pemsingh RS, Scott GW. Experimental cholelithiasis in the ground squirrel. Lab Invest 1987;56:138-145.
11. Smith BF, LaMont JT, Small DM. The sequence of events in gallstone formation. Lab Invest 1987;56:125-127.
12. Xu QW, Shaffer EA. Cisapride improves gallbladder contractility and bile lipid composition in an animal model of gallstone disease. Gastroenterology 1993;105:1184-1191.
13. Xu QW, Scott RB, Tan D, Shaffer EA. Slow intestinal transit: a motility disorder contributing to cholesterol gallstone formation in the ground squirrel. HEPATOLOGY 1996;23:1664-1672.
14. Pauletzki JG, Xu QW, Shaffer EA. Biliary hypomotility decreases cholesterol saturation in bile in the Richardson ground squirrel. HEPATOLOGY 1995;22:325-331.
15. Roslyn JJ, DenBesten L, Pitt H, Kuchenbecker S, Polarek JW. Effect of cholecystokinin on gallbladder stasis and cholesterol gallstone formation. J Surg Res 1981;30:200-204.
16. Doty JE, Pitt HA, Porter-Fink V, DenBesten L. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease. Ann Surg 1985;201:76-80.
17. Carey MC, Duane WC. Enterohepatic circulation. In: Arias IM et al., eds. The Liver: Biology and Pathobiology. 3rd ed. New York: Raven, 1994:719-768.
18. Carey MC, Cahalane MJ. Whither biliary sludge? Gastroenterology 1988;95:508-523.
19. Holan KR, Holzbach RT, Hermann RE, Cooperman A, Claffey NJ. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979;77:611-617.
20. Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 1977; 59:828-840.
21. Berr F, Stellaard F, Pratschke E, Paumgartner G. Effects of cholecystectomy on the kinetics of primary and secondary bile acids. J Clin Invest 1989;83:1541-1550.
22. Stolk MFJ, van Erpecum KJ, Renooij W, Portincasa P, van de Heijning BJM, van Berge-Henegouwen GP. Gallbladder emptying in vivo, bile composition and nucleation of cholesterol crystals in patients with cholesterol gallstones. Gastroenterology 1995;108:1882-1888.
23. Lee SP, LaMont JT, Carey MC. Role of gallstone mucus hypersecretion in the evolution of cholesterol gallstone: studies in a prairie dog. J Clin Invest 1981;67:1712-1723.
24. Lee SP, Maher K, Nicholls JF. Origin and fate of biliary sludge. Gastroenterology 1988;94:170-176.
25. Harvey PRC, Rupar CA, Gallinger S, Petrunka CN, Strasberg SM. Quantitative and qualitative comparison of gallbladder mucus glycoprotein from patients with and without gallstones. Gut 1985;27:374-381.
26. Halpern Z, Dudley MA, Kibe A, Lynn MP, Breuer AC, Holzbach RT. Rapid vesicle formation and aggregation in abnormal human bile. A time-lapse video-enhanced contrast microscopy study. Gastroenterology 1985;90:875-885.
27. Afdhal NH, Niu N, Gantz D, Small DM, Smith BF. Bovine gallbladder mucin accelerates cholesterol monohydrate crystal growth in model bile. Gastroenterology 1993;104:1515-1523.
28. Afdhal NH, Niu N, Nunes DP, Bansil R, Cao XX, Gantz D, Small DM, et al. Mucin-vesicle interactions in model bile: evidence for vesicle aggregation and fusion before cholesterol crystal formation. HEPATOLOGY 1995;22:856-865.
29. Chang RSL, Lotti V. Biochemical and pharmacological characterization of an extremely potent and selective non-peptide cholecystokinin antagonist. Proc Natl Acad Sci U S A 1986;83:4923-4926.
30. Liddle RA, Gertz BJ, Kanayama S, Beccaria L, Coker LD, Turnbull TA, Morita ET. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. J Clin Invest 1989;84:1220-1225.
31. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:945-955.
32. Mantle M, Thakore E, Atkins E, Mathison R, Davison JS. Effects of streptozotocin-diabetes on rat intestinal mucin and goblet cells. Gastroenterology 1989;97:68-75.
33. Hinegardner RT. An improved fluorometric assay for DNA. Anal Biochem 1971;39:197-201.
34. Jungst D, Lang T, Von Titter C, Pratschke E, Paumgartner G. Cholesterol nucleation time in gallstone bile of patients with solitary or multiple cholesterol gallstones. HEPATOLOGY 1992;15:804-808.
35. Harvey PRC, Strasberg SM. Will the real cholesterol nucleating and anti-nucleating proteins please stand up. Gastroenterology 1993;104: 646-650.
36. Jazrawi RP, Pazzi P, Petroni ML, Prandini N, Paul C, Adam JA, Gullini S, et al. Postprandial gallbladder motor function: refilling and turnover of bile in health and in cholelithiasis. Gastroenterology 1995;109:582-591.
37. Kibe A, Dudley MA, Halpern Z, Lynn MP, Breuer AC, Holzbach RT. Factors affecting cholesterol monohydrate crystal nucleation time in model systems of supersaturated bile. J Lipid Res 1985;26:1102-1111.
38. Small MD, Rapo S. The source of abnormal bile in patients with cholesterol gallstones. N Engl J Med 1970;283:53-57.
39. Harvey PRC, Uphadya GA, Strasberg SM. Immunoglobulins as nucleating agents in the gallbladder bile of patients with cholesterol gallstones. J Biol Chem 1991;2266:13996-14003.
40. 1-acid glycoprotein, phospholipase C and aminopeptidase N. J Lipid Res 1993;34:1141-1148.
41. Yamashita G, Corradini SG, Secknus R, Takabayashi A, Williams C, Hays L, Chernosky AL, et al. Biliary haptoglobin, a potent promoter of cholesterol crystallization at physiological concentrations. J Lipid Res 1995;36:1325-1333.